17-carbamoyloxy cortisol derivatives as selective...

Details 17-carbamoyloxy cortisol derivatives as selective... 17-carbamoyloxy cortisol derivatives as selective...

2004-01-16

2010-06-08

Badio, Barbara P (Department: 1628)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

C514S179000, C552S570000

Reexamination Certificate

active

07732432

ABSTRACT:
The present invention encompasses compounds of Formula (I) or pharmaceutically acceptable salts or hydrates thereof, which are useful as selective glucocorticoid receptor ligands for treating a variety of autoimmune and inflammatory diseases or conditions. Pharmaceutical compositions and methods of use are also included.

REFERENCES:
patent: 4328221 (1982-05-01), Szilagyi nee Farago et al.
patent: 4397782 (1983-08-01), Varma
patent: 0 496 520 (1992-07-01), None
patent: WO 98/20151 (1998-05-01), None
patent: WO 00/48572 (2000-08-01), None
Souillac, et al., Characterization of Delivery Systems, Differential Scanning Calorimetry, pp. 217-218 (in Encyclopedia of Controlled Drug Delivery, 1999, John Wiley & Sons, pp. 212-227).
Vippagunta et al. (Advanced Drug Delivery Reviews, 48 (2001), pp. 3-26).
Farenholtz, et al. “Steroidal Imidazole-1-carboxylic Acid Esters”, Journal of Medicinal Chemistry, 1974, 17(3), p. 337-342.

Affiliated with

Also associated with

Rating

17-carbamoyloxy cortisol derivatives as selective... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 17-carbamoyloxy cortisol derivatives as selective..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 17-carbamoyloxy cortisol derivatives as selective... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4229853